Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zaotang protein capsule is an immunomodulatory pharmaceutical product developed by Weifang Shuyi Pharmaceutical Co., Ltd. It is composed of glycoproteins extracted from the fruit of *Ziziphus jujuba* (Chinese date). The primary therapeutic application of this drug is the treatment of leukopenia, particularly when induced by radiotherapy or chemotherapy, as it stimulates the proliferation of bone marrow cells and enhances the production of white blood cells. Additionally, it is utilized or investigated for its potential to bolster the immune system in the management of viral infections, including influenza, by modulating cytokine activity and improving overall immune resilience.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zaotang protein capsule.